Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Healthtrust
Moodys
UBS
Baxter

Generated: August 25, 2019

DrugPatentWatch Database Preview

Claims for Patent: 8,795,959

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,795,959
Title:Isolated glucokinase genomic polynucleotide fragments from chromosome 7
Abstract: Provided are isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50 kD regulatory subunit (POLD2), vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain SNARE YKT6, human glucokinase, AEBP1 protein and POLD2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Inventor(s): Ryan; James (Augusta, GA)
Assignee: Ryogen LLC (Suffern, NY)
Application Number:13/680,178
Patent Claims:1. A method of identifying a nucleotide sequence variant of a 5'-noncoding region, 3'-noncoding region or intron region of SEQ ID NO:6, wherein said variant encodes a protein that has human glucokinase activity, wherein SEQ ID NO:6 consists of a 5'-noncoding region shown in sequence segment 1-20484 of SEQ ID NO:6, a 3'-non coding region shown in sequence segment 33461-45,980 of SEQ ID NO:6, exon regions shown in sequence segments 20485-20523, 25133-25297, 26173-26328, 27524-27643, 28535-28630, 29740-28838, 30765-30950, 31982-32134, 32867-33097, 3331433460 of SEQ ID NO:6, and intron regions shown in sequence segments 20524-25132, 25298-26172, 26329-27523, 27644-28534, 28631-28739, 28839-30764, 30951-31981, 32135-32866, 33098-33313 of SEQ ID NO:6; or its complementary sequence comprising (a) isolating genomic polynucleotide from a sample and (b) determining the presence or absence of a nucleotide sequence variation in said genomic polynucleotide by comparing the nucleotide sequence of SEQ ID NO:6 with the nucleotide sequence of the isolated genomic polynucleotide and establishing if and where a difference occurs between the two nucleic acid sequences thereby identifying a nucleotide sequence variant of SEQ ID NO:6 or its complement.

2. A method for detecting the presence of: (a) a nucleic acid molecule 45,980 nucleotides in length which is at least 99% identical to SEQ ID NO:6 which encodes a polypeptide that has human glucokinase activity, wherein SEQ ID NO:6 consists of a 5'-noncoding region shown in sequence segment 1-20484 of SEQ ID NO:6, a 3'-non coding region shown in sequence segment 33461-45,980 of SEQ ID NO:6, exon regions shown in sequence segments 20485-20523, 25133-25297, 26173-26328, 27524-27643, 28535-28630, 29740-28838, 30765-30950, 31982-32134, 32867-33097, 33314-33460 of SEQ ID NO:6, and intron regions shown in sequence segments 20524-25132, 25298-26172, 26329-27523, 27644-28534, 28631-28739, 28839-30764, 30951-31981, 32135-32866, 33098-33313 of SEQ ID NO:6; (b) a fragment of (a), comprising at least nucleotides 20485-33460 of SEQ ID NO:6 which encodes a polypeptide having human glucokinase activity and (c) a nucleic acid molecule which is a complement of the nucleic acid molecules specified in (a)-(b) in a sample, comprising contacting the sample with a polynucleotide probe comprising at least 20 contiguous nucleotides that hybridizes to said nucleic acid molecule under stringent conditions and determining whether the polynucleotide probe binds to said nucleic acid molecule in the sample.

Details for Patent 8,795,959

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Ryogen LLC (Suffern, NY) 2020-09-21 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Ryogen LLC (Suffern, NY) 2020-09-21 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Ryogen LLC (Suffern, NY) 2020-09-21 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
Covington
Teva
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.